TORRENT PHARMACEUTICALS SHARE PRICE TARGET OF 2023,2024,2025 TO 2030

0 Shares

Torrent Pharma, a flagship company of the Torrent Group, stands as one of the foremost pharmaceutical firms in the country. Notably, the company played a pioneering role in introducing niche marketing in India.

Furthermore, Torrent Pharma has established a significant presence in diverse medical fields. The company’s competitive edge lies in its world-class manufacturing facilities, advanced research and development capabilities, extensive domestic network, and global outreach spanning across more than 40 countries.

It stands as a prominent Indian pharmaceutical company actively involved in the research, development, manufacturing, and marketing of generic pharmaceutical formulations.

This article aims to explore the share price target of Torrent Pharmaceuticals from 2023 to 2030, as well as analyze the viability of Torrent Pharmaceuticals as a promising stock to consider for investment.

LATEST NEWS ABOUT TORRENT PHARMACEUTICALS

In the fourth quarter, Torrent Pharma returned to profitability and announced a dividend of Rs 8.
Investors who put their money into Torrent Pharmaceuticals (NSE:TORNTPHARM) five years ago have seen a remarkable 194% increase in their investment.
The Indian pharmaceutical industry is well-positioned to capitalize on a substantial opportunity in the US generics market- Torrent Pharmaceuticals is one of the top player.

HOW TO BUY TORRENT PHARMACEUTICALS SHARES ?

You can buy Torrent Pharmaceuticals shares from the following trading platforms:

Zerodha
Upstox
Groww
AngleOne
ICICIDirect

SHARE PRICE PREDICTION OF TORRENT PHARMACEUTICALS :2023 TO 2030

SHARE PRICE TARGET 2023 OF TORRENT PHARMACEUTICALS

When	Maximum Price	Minimum Price
July 2023	₹2,020.20	₹1,836.55
August 2023	₹2,060.60	₹1,873.28
September 2023	₹2,108.00	₹1,916.36
October 2023	₹2,046.60	₹1,860.55
November 2023	₹2,087.53	₹1,897.76
December 2023	₹2,150.16	₹1,954.69

In 2023, Torrent Pharmaceuticals has set an ambitious share price target, projecting steady growth throughout the year. The share price is expected to start at a minimum of ₹1,836.55 in July and reach a maximum of ₹2,150.16 by December, showcasing a significant potential for appreciation. The growth trajectory indicates an upward trend with a progressive increase in the share price each month. Investors may witness a growth percentage of approximately 17.1% from July to December, considering the difference between the maximum and minimum prices during this period. This optimistic outlook reflects the company’s efforts in tapping into opportunities in the pharmaceutical market and aligning with the positive industry dynamics. However, as with any investment, it is essential for investors to carefully analyze market conditions and other relevant factors before making decisions.

SHARE PRICE TARGET 2024 OF TORRENT PHARMACEUTICALS

When	Maximum Price	Minimum Price
January 2024	₹2,263.32	₹1,968.11
February 2024	₹2,460.13	₹2,139.25
March 2024	₹2,484.98	₹2,160.86
April 2024	₹2,259.08	₹1,964.41
May 2024	₹1,882.56	₹1,637.01
June 2024	₹2,259.08	₹1,964.41
July 2024	₹1,920.22	₹1,669.75
August 2024	₹2,112.24	₹1,836.73
September 2024	₹2,217.85	₹1,928.56
October 2024	₹2,609.23	₹2,268.90
November 2024	₹2,739.70	₹2,382.34
December 2024	₹2,794.49	₹2,429.99

In 2024, Torrent Pharmaceuticals is expected to experience fluctuations in its share price, presenting both opportunities and challenges for investors. The share price target for the company varies throughout the year, with a minimum price of ₹1,637.01 in May and a maximum price of ₹2,794.49 in December.

Analyzing the growth percentage for 2024, we observe that the share price starts at ₹1,968.11 in January and reaches ₹2,429.99 in December, reflecting an overall growth of approximately 23.4% during the year.

This growth percentage suggests that Torrent Pharmaceuticals is aiming to maintain a positive trajectory despite market fluctuations. Investors may closely monitor the company’s performance, financial results, and other market factors to make informed decisions regarding their investments.

It is important to consider that the pharmaceutical industry can be influenced by numerous factors, including regulatory changes, product developments, competition, and overall market conditions. As such, the share price target and growth percentage are subject to change based on the company’s performance and external influences.

SHARE PRICE TARGET 2025 OF TORRENT PHARMACEUTICALS

When	Maximum Price	Minimum Price
January 2025	₹2,850.38	₹2,192.60
February 2025	₹3,000.40	₹2,308.00
March 2025	₹3,150.42	₹2,423.40
April 2025	₹2,812.87	₹2,163.75
May 2025	₹2,557.16	₹1,967.04
June 2025	₹2,812.87	₹2,163.75
July 2025	₹2,678.93	₹2,060.71
August 2025	₹2,790.55	₹2,146.58
September 2025	₹2,930.08	₹2,253.91
October 2025	₹3,105.88	₹2,389.14
November 2025	₹3,323.29	₹2,556.38
December 2025	₹3,389.76	₹2,607.51

In 2025, Torrent Pharmaceuticals is projected to witness fluctuations in its share price, providing potential opportunities and challenges for investors. The share price target for the company varies throughout the year, with a minimum price of ₹1,967.04 in May and a maximum price of ₹3,389.76 in December.

Assessing the growth percentage for 2025, we observe that the share price begins at ₹2,192.60 in January and culminates at ₹2,607.51 in December, reflecting an overall growth of approximately 19%. This growth percentage indicates that Torrent Pharmaceuticals is striving to maintain positive momentum despite market volatility.

Investors are advised to closely monitor the company’s performance, financial results, and industry dynamics to make informed investment decisions. The pharmaceutical sector is influenced by various factors such as regulatory changes, product developments, competitive landscape, and overall economic conditions, which can impact the share price.

TORRENT PHARMACEUTICALS SHARE PRICE PREDICTION 2026-2030

Year	Maximum Price	Minimum Price
2026	₹2,372.83	₹1,660.98
2027	₹2,016.91	₹1,411.83
2028	₹3,630.43	₹2,541.30
2029	₹7,457.47	₹5,220.23
2030	₹8,304.91	₹5,813.44

Based on the provided data, we can observe the historical maximum and minimum share prices for Torrent Pharmaceuticals for the years 2026 to 2030.

In the year 2026, the share price ranged from a minimum of ₹1,660.98 to a maximum of ₹2,372.83.Moving on to 2027, the share price experienced a narrower range, with a minimum of ₹1,411.83 and a maximum of ₹2,016.91.

The year 2028 saw significant growth in the share price, with the range extending from ₹2,541.30 to ₹3,630.43.Continuing to 2029, the share price further surged, reaching a maximum of ₹7,457.47 and a minimum of ₹5,220.23.

Finally, in 2030, the share price continued its upward trajectory, with a range between ₹5,813.44 and ₹8,304.91.

These historical share price trends indicate that Torrent Pharmaceuticals experienced substantial growth over the years, presenting both potential opportunities and risks for investors. The pharmaceutical industry’s performance and other market factors are likely to continue influencing the company’s share price in the future. Investors should stay vigilant, conduct thorough research, and seek professional advice while making investment decisions in the pharmaceutical sector.

FINANCIAL CONDITION OF TORRENT PHARMACEUTICALS :LAST 5 YEARS

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales	7,673	7,939	8,005	8,508	9,620
Expenses	5,690	5,769	5,524	6,077	6,778
Operating Profit	1,983	2,170	2,480	2,431	2,842
OPM %	26%	27%	31%	29%	30%
Other Income	-300	121	57	-288	45
Interest	504	451	353	255	333
Depreciation	618	654	658	662	707
Profit before tax	562	1,187	1,526	1,226	1,847
Tax %	22%	14%	18%	37%	33%
Net Profit	436	1,025	1,252	777	1,245
EPS in Rs	12.89	30.28	36.99	22.97	36.79
Dividend Payout %	66%	53%	47%	105%	60%

There has been consistent growth in sales over the years, with revenues increasing from ₹7,673 million in March 2019 to ₹9,620 million in March 2023.Operating expenses have fluctuated but have generally shown an upward trend. They rose from ₹5,690 million in March 2019 to ₹6,778 million in March 2023.The operating profit has shown overall growth, reaching ₹2,842 million in March 2023, despite minor fluctuations in certain years. Operating Profit Margin (OPM %): The operating profit margin has been relatively stable, fluctuating between 26% and 31%, with the highest margin recorded in March 2021.

The company experienced fluctuations in other income, with negative values in March 2019 and March 2022. However, there has been some recovery, with other income reaching ₹45 million in March 2023. Interest expenses decreased over the years, falling from ₹504 million in March 2019 to ₹333 million in March 2023.Depreciation expenses have remained relatively consistent, with a gradual increase from ₹618 million in March 2019 to ₹707 million in March 2023.

The EPS has followed an overall upward trend, increasing from ₹12.89 in March 2019 to ₹36.79 in March 2023. Dividend Payout %: The dividend payout percentage varied, reaching 105% in March 2022, indicating a higher payout than the net profit for that particular year.

Overall, Torrent Pharmaceuticals has demonstrated growth in revenues and profitability over the years, with some fluctuations in expenses and profit margins. Investors should consider these financial indicators alongside other market factors when making investment decisions.

FAQS

How Has Torrent Pharmaceuticals Performed In Terms Of Sales Over The Years ?

There has been consistent growth in sales over the years, with revenues increasing from ₹7,673 million in March 2019 to ₹9,620 million in March 2023.

What Has Been The Trend In Torrent Pharmaceutical’s Earnings Per Share (EPS)?

The EPS has followed an overall upward trend, increasing from ₹12.89 in March 2019 to ₹36.79 in March 2023.

What Is The Share Price Target Of Torrent Pharmaceuticals For 2025?

Torrent Pharmaceuticals share price might reach around ₹3,390 by the end of 2025.

What Is The Share Price Target Of Torrent Pharmaceuticals For 2030?

Torrent Pharmaceuticals share price might reach around ₹8,304 by the end of 2030.

Is Torrent A Good Share To Buy ?

Torrent is considered an appealing long-term investment choice due to its strong presence in various sectors and a consistent history of financial expansion, though it is essential to acknowledge the inherent risks that come with any stock investment.

Also Read:

CONCLUSION

Based on the provided financial performance data for Torrent Pharmaceuticals over the years, it is evident that the company has shown a positive growth trajectory, with consistent increases in sales and net profit. The pharmaceutical industry’s potential for growth and the company’s efforts to tap into opportunities in therapeutic segments have contributed to its overall financial expansion.

Investors may find Torrent Pharmaceuticals to be an attractive option for long-term investment, given its robust presence in various therapeutic areas and its continuous efforts to develop and market generic pharmaceutical formulations. The company’s competitive advantage, such as world-class manufacturing facilities and extensive research and development capabilities, further bolster its growth prospects.

However, it is essential to consider the inherent risks associated with investing in any stock, including the pharmaceutical sector. Factors such as regulatory changes, market competition, and other industry-specific challenges can impact the company’s performance and stock value.

Sonam